The Priority Review

Tag

HSCT-TMA

1 story

Stories

  1. Clinical trials

    Alexion posts results of Phase 3 ravulizumab trial in HSCT-TMA

    The study enrolled 148 participants and completed primary data collection on September 19, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.